Journal Article

Pre-existing immunity to influenza virus hemagglutinin stalk might drive selection for antibody-escape mutant viruses in a human challenge model

Walters, Kathie-Anne, Fong, Sharon, Athota, Rani, Batchenkova, Natalia A., Ramuta, Mitchell D., Memoli, Matthew J., Han, Alison, Park, Jae-Keun, Scherler, Kelsey, Gouzoulis, Monica A., Yang, Xingdong, Morens, David M., Taubenberger, Jeffery K., Kash, John C., Freeman, Ashley D., Xiao, Yongli, Rosas, Luz Angela, Matthews, Alexis M., Qi, Li, Reed, Susan, Czajkowski, Lindsay

2020

Overview

The conserved region of influenza hemagglutinin (HA) stalk (or stem) has gained attention as a potent target for universal influenza vaccines 1 , 2 , 3 , 4 – 5 . Although the HA stalk region is relatively well conserved, the evolutionarily dynamic nature of influenza viruses 6 raises concerns about the possible emergence of viruses carrying stalk escape mutation(s) under sufficient immune pressure. Here we show that immune pressure on the HA stalk can lead to expansion of escape mutant viruses in study participants challenged with a 2009 H1N1 pandemic influenza virus inoculum containing an A388V polymorphism in the HA stalk (45% wild type and 55% mutant). High level of stalk antibody titers was associated with the selection of the mutant virus both in humans and in vitro. Although the mutant virus showed slightly decreased replication in mice, it was not observed in cell culture, ferrets or human challenge participants. The A388V mutation conferred resistance to some of the potent HA stalk broadly neutralizing monoclonal antibodies (bNAbs). Co-culture of wild-type and mutant viruses in the presence of either a bNAb or human serum resulted in rapid expansion of the mutant. These data shed light on a potential obstacle for the success of HA-stalk-targeting universal influenza vaccines—viral escape from vaccine-induced stalk immunity. High levels of antibodies specific for the stalk region of influenza hemagglutinin protein are associated with expansion of mutant viruses in human volunteers, suggesting potential challenges for influenza vaccine efforts targeting the HA stalk.

• Publisher: Nature Publishing Group US,Nature Publishing Group
• Subject: 631/326/596/1578 / 631/326/596/2558 / Animals / Antibodies, Neutralizing - genetics / Antibodies, Neutralizing - immunology / Antibodies, Neutralizing - pharmacology / Antibodies, Viral - genetics / Antibodies, Viral - immunology / Antibodies, Viral - pharmacology / Biomedical and Life Sciences / Biomedicine / Cancer Research / Cell culture / Conserved Sequence - genetics / Cross Reactions - immunology / Disease resistance / Genetic aspects / Health aspects / Hemagglutinin Glycoproteins, Influenza Virus - genetics / Hemagglutinin Glycoproteins, Influenza Virus - immunology / Hemagglutinins / Humans / Immunity / Infectious Diseases / Influenza / Influenza A Virus, H1N1 Subtype - genetics / Influenza A Virus, H1N1 Subtype - immunology / Influenza A Virus, H1N1 Subtype - pathogenicity / Influenza vaccines / Influenza Vaccines - genetics / Influenza Vaccines - immunology / Influenza viruses / Influenza, Human - genetics / Influenza, Human - immunology / Influenza, Human - prevention & control / Influenza, Human - virology / Inoculum / Letter / Metabolic Diseases / Mice / Molecular Medicine / Monoclonal antibodies / Mutants / Mutation / Neurosciences / Pandemics / Pharmacology, Experimental / Physiological aspects / Polymorphism / Selection, Genetic - genetics / Selection, Genetic - immunology / Vaccines / Viruses